Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1992 Oct;68(4):392–397. doi: 10.1136/hrt.68.10.392

Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality

Jaswinder S Gill 1, Davendra Mehta 1, David E Ward 1, A John Camm 1
PMCID: PMC1025139  PMID: 1449923

Abstract

Objective—A comparison of the efficacy of verapamil, sotalol, and flecainide to suppress right ventricular tachycardia (VT) in patients with a clinically normal heart.

Design—Patients underwent treatment serially with verapamil (360 mg daily), sotalol (240 or 320 mg daily), and flecainide (200 or 300 mg daily), (the larger dose was for patients heavier than 80 kg) to suppress tachycardia. Each drug was given orally for five half lives before testing.

Patients—23 patients with right VT associated with a clinically normal heart were studied.

Outcome measures—The effects of drug treatment were examined by the number of ventricular events on 24 hour Holter monitoring, and the ability of tachycardia to be induced by treadmill exercise testing (Bruce protocol) and programmed ventricular stimulation (Wellens protocol), compared with drug free baseline tests.

Setting—Patients were studied in a tertiary referral centre.

Results—All three drugs suppressed ventricular salvos (>3, <5 consecutive ventricular premature contractions) (p < 0·01) and VT (p < 0·05) on Holter monitoring and did not differ statistically in effect. Exercise induced VT was also suppressed by all three drugs (p < 0·01), and of these sotalol was the most effective although this was not statistically significant (14/23 inducible when drug free, 4/23 on flecainide, 2/23 on sotalol, 5/23 on verapamil). Sustained and nonsustained VT induced by programmed stimulation was also suppressed by the three drugs (p < 0·01) and again sotalol was the best of these though the differences did not achieve statistical significance (17/23 inducible when drug free, 4/17 on flecainide, 2/17 on sotalol, and 6/17 on verapamil). Proarrhythmic effects of drugs were found in a few patients. There was no difference in the efficacy of the drugs in patients with histological abnormalities of the myocardium when compared with those of normal histology.

Conclusions—Ventricular tachycardia associated with a clinically normal heart can be suppressed by flecainide, sotalol, or verapamil. In individual patients sotalol was the most frequently effective drug (effective in >89% of patients) and is a suitable choice for first line treatment.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benson D. W., Jr, Benditt D. G., Anderson R. W., Dunnigan A., Pritzker M. R., Kulik T. J., Zavoral J. H. Cardiac arrest in young, ostensibly healthy patients: clinical, hemodynamic, and electrophysiologic findings. Am J Cardiol. 1983 Jul;52(1):65–69. doi: 10.1016/0002-9149(83)90070-x. [DOI] [PubMed] [Google Scholar]
  2. Brodsky M. A., Sato D. A., Allen B. J., Chesnie B. M., Henry W. L. Solitary beta-blocker therapy for idiopathic life-threatening ventricular tachyarrhythmias. Chest. 1986 Jun;89(6):790–794. doi: 10.1378/chest.89.6.790. [DOI] [PubMed] [Google Scholar]
  3. Bruce R. A., Hornsten T. R. Exercise stress testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis. 1969 Mar;11(5):371–390. doi: 10.1016/0033-0620(69)90027-9. [DOI] [PubMed] [Google Scholar]
  4. Buxton A. E., Waxman H. L., Marchlinski F. E., Simson M. B., Cassidy D., Josephson M. E. Right ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation. 1983 Nov;68(5):917–927. doi: 10.1161/01.cir.68.5.917. [DOI] [PubMed] [Google Scholar]
  5. Chapman J. H., Schrank J. P., Crampton R. S. Idiopathic ventricular tachycardia. An intracardiac electrical, hemodynamic and angiographic assessment of six patients. Am J Med. 1975 Oct;59(4):470–480. doi: 10.1016/0002-9343(75)90254-5. [DOI] [PubMed] [Google Scholar]
  6. Deal B. J., Miller S. M., Scagliotti D., Prechel D., Gallastegui J. L., Hariman R. J. Ventricular tachycardia in a young population without overt heart disease. Circulation. 1986 Jun;73(6):1111–1118. doi: 10.1161/01.cir.73.6.1111. [DOI] [PubMed] [Google Scholar]
  7. FROMENT R., GALLAVARDIN L., CAHEN P. Paroxysmal ventricular tachycardia; a clinical classification. Br Heart J. 1953 Apr;15(2):172–178. doi: 10.1136/hrt.15.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Holt P. M., Wainwright R. J., Curry P. V. Right ventricular outflow tract tachycardias in patients without apparent structural heart disease. Int J Cardiol. 1986 Feb;10(2):99–110. doi: 10.1016/0167-5273(86)90217-2. [DOI] [PubMed] [Google Scholar]
  9. Lemery R., Brugada P., Bella P. D., Dugernier T., van den Dool A., Wellens H. J. Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease. Circulation. 1989 May;79(5):990–999. doi: 10.1161/01.cir.79.5.990. [DOI] [PubMed] [Google Scholar]
  10. Lerman B. B., Belardinelli L., West G. A., Berne R. M., DiMarco J. P. Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation. 1986 Aug;74(2):270–280. doi: 10.1161/01.cir.74.2.270. [DOI] [PubMed] [Google Scholar]
  11. Mehta D., McKenna W. J., Ward D. E., Davies M. J., Camm A. J. Significance of signal-averaged electrocardiography in relation to endomyocardial biopsy and ventricular stimulation studies in patients with ventricular tachycardia without clinically apparent heart disease. J Am Coll Cardiol. 1989 Aug;14(2):372–381. doi: 10.1016/0735-1097(89)90188-5. [DOI] [PubMed] [Google Scholar]
  12. Mehta D., Odawara H., Ward D. E., McKenna W. J., Davies M. J., Camm A. J. Echocardiographic and histologic evaluation of the right ventricle in ventricular tachycardias of left bundle branch block morphology without overt cardiac abnormality. Am J Cardiol. 1989 Apr 15;63(13):939–944. doi: 10.1016/0002-9149(89)90144-6. [DOI] [PubMed] [Google Scholar]
  13. Palileo E. V., Ashley W. W., Swiryn S., Bauernfeind R. A., Strasberg B., Petropoulos A. T., Rosen K. M. Exercise provocable right ventricular outflow tract tachycardia. Am Heart J. 1982 Aug;104(2 Pt 1):185–193. doi: 10.1016/0002-8703(82)90190-9. [DOI] [PubMed] [Google Scholar]
  14. Pietras R. J., Lam W., Bauernfeind R., Sheikh A., Palileo E., Strasberg B., Swiryn S., Rosen K. M. Chronic recurrent right ventricular tachycardia in patients without ischemic heart disease: clinical, hemodynamic, and angiographic findings. Am Heart J. 1983 Mar;105(3):357–366. doi: 10.1016/0002-8703(83)90350-2. [DOI] [PubMed] [Google Scholar]
  15. Proclemer A., Ciani R., Feruglio G. A. Right ventricular tachycardia with left bundle branch block and inferior axis morphology: clinical and arrhythmological characteristics in 15 patients. Pacing Clin Electrophysiol. 1989 Jun;12(6):977–989. doi: 10.1111/j.1540-8159.1989.tb05035.x. [DOI] [PubMed] [Google Scholar]
  16. Rahilly G. T., Prystowsky E. N., Zipes D. P., Naccarelli G. V., Jackman W. M., Heger J. J. Clinical and electrophysiologic findings in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram. Am J Cardiol. 1982 Sep;50(3):459–468. doi: 10.1016/0002-9149(82)90310-1. [DOI] [PubMed] [Google Scholar]
  17. Rowland T. W., Schweiger M. J. Repetitive paroxysmal ventricular tachycardia and sudden death in a child. Am J Cardiol. 1984 Jun 1;53(11):1729–1729. doi: 10.1016/0002-9149(84)90614-3. [DOI] [PubMed] [Google Scholar]
  18. Strain J. E., Grose R. M., Factor S. M., Fisher J. D. Results of endomyocardial biopsy in patients with spontaneous ventricular tachycardia but without apparent structural heart disease. Circulation. 1983 Dec;68(6):1171–1181. doi: 10.1161/01.cir.68.6.1171. [DOI] [PubMed] [Google Scholar]
  19. Sugrue D. D., Holmes D. R., Jr, Gersh B. J., Edwards W. D., McLaran C. J., Wood D. L., Osborn M. J., Hammill S. C. Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin. J Am Coll Cardiol. 1984 Nov;4(5):952–957. doi: 10.1016/s0735-1097(84)80056-x. [DOI] [PubMed] [Google Scholar]
  20. Thiene G., Nava A., Corrado D., Rossi L., Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988 Jan 21;318(3):129–133. doi: 10.1056/NEJM198801213180301. [DOI] [PubMed] [Google Scholar]
  21. Wellens H. J., Brugada P., Stevenson W. G. Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol? Circulation. 1985 Jul;72(1):1–7. doi: 10.1161/01.cir.72.1.1. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES